• CFTRinh-172: A Functional Lens on CFTR Trafficking

  2026-08-28

  CFTRinh-172 is a selective CFTR inhibitor that helps separate channel activity from plasma-membrane abundance. This article presents a causal assay framework linking acute transport blockade with emerging CFTR trafficking research across epithelial models.

• Losmapimod: p38 MAPK Mechanism and Research Use

  2026-08-28

  Losmapimod, also called GW856553X, is an orally active inhibitor of p38α and p38β MAPK with reported pKi values of 8.1 and 7.6. Research findings connect this target profile with inflammation signaling modulation, vascular function improvement, and investigation in hypertension and chronic obstructive pulmonary disease (COPD) models.

• GCG Disrupts SARS-CoV-2 N-Protein Condensation

  2026-08-27

  The reference study identifies RNA-driven liquid–liquid phase separation of the SARS-CoV-2 nucleocapsid protein N as a mechanism linked to viral organization and replication. It further shows that the R203K/G204R variant increases condensation-related activity, while (-)-gallocatechin gallate disrupts N–RNA condensation and suppresses viral replication, establishing a mechanistic starting point for antiviral research.

• Latrunculin A: Reading Actin Perturbation

  2026-08-27

  Latrunculin A is a reversible inhibitor of actin assembly that can reveal how cytoskeletal state shapes cellular phenotypes and viral replication. This article translates recent actin–myosin II findings into a practical framework for designing, controlling, and interpreting perturbation assays.

• Birinapant (TL32711) CRC Apoptosis Workflow

  2026-08-26

  Birinapant (TL32711) provides a mechanistically defined way to test IAP-dependent apoptosis resistance alongside MDM1, p53, chemoradiation, TNF, or TRAIL models. This workflow connects cIAP1/2 degradation and caspase-8 activation with practical assay controls, dosing logic, and troubleshooting guidance.

• Stattic: Mechanism, Evidence, and Workflow

  2026-08-26

  Stattic is a small-molecule STAT3 inhibitor used to study STAT3 dimerization, transcriptional signaling, apoptosis induction in cancer cells, and radiosensitization. Product and peer-reviewed evidence support pathway-focused use in cancer biology, while the available evidence does not establish Stattic as a clinical treatment.

• ROS-Responsive Nanoparticles for Cuproptosis Therapy

  2026-08-25

  The reference study developed ROS-responsive PHPM nanoparticles that co-deliver elesclomol and copper to intensify cuproptosis in bladder cancer models. Its combination with αPD-L1 links copper-dependent tumor killing to tumor-microenvironment remodeling and provides a mechanistic rationale for integrating nanomedicine with immune checkpoint blockade.

• ECL Chemiluminescent Substrate Detection Kit Guide

  2026-08-25

  Learn how to use an Enhanced ECL detection kit for sensitive western blot validation of ferroptosis and PI3K/Akt/GPX4 signaling in renal cell carcinoma research. The workflow combines low-picogram protein immunodetection, extended signal stability, and practical troubleshooting for reproducible antibody detection assays.

• ARCA EGFP mRNA (5-moUTP) Control Guide

  2026-08-24

  ARCA EGFP mRNA (5-moUTP) is a polyadenylated mRNA reporter for direct EGFP detection after mRNA transfection in mammalian cells. Its ARCA cap, 5-methoxyuridine modification, and optimized poly(A) tail support a reproducible fluorescence-based transfection control workflow.

• Syringin in RCC Signaling Research

  2026-08-23

  Use Syringin as a mechanistic research tool to connect RCC viability, migration, apoptosis, and EGFR/PI3K/Akt signaling in the same experimental program. Its combination with sunitinib creates a differentiated workflow for studying drug sensitivity and resistance rather than measuring cytotoxicity alone.

• Thymoquinone Protects Against Doxorubicin Cardiotoxicity

  2026-08-22

  A 2025 study provides in vivo evidence that Thymoquinone reduces doxorubicin-induced cardiac injury in mice. Its protective effects were associated with activation of the Nrf2/HO-1 antioxidant axis, preservation of ferroptosis-related proteins, reduced oxidative stress, and protection of mitochondrial structure.

• Polymeric Nanoplatform Activates STING in TAMs

  2026-08-21

  A 2024 Journal of Controlled Release study developed M-PNP@R@C, a mannose-modified, pH-responsive polymeric nanoplatform that co-delivers R848 and cGAMP to tumor-associated macrophages. The approach connected STING activation with fatty-acid-oxidation-associated SIRPα downregulation, enhancing macrophage phagocytosis and improving the activity of anti-CD47 and anti-PD-L1 combinations in preclinical cancer models.

• Relative vs Fractional Viability in Cancer Drug Testing

  2026-08-20

  Hannah R. Schwartz’s dissertation distinguishes relative viability from fractional viability, separating composite growth inhibition from direct cell killing in anticancer drug assays. Its findings show that drugs can affect proliferation and death in different proportions and on different timelines, supporting more informative experimental design and interpretation.

• Propranolol Beyond β-Blockade: A Translational Roadmap

  2026-08-20

  Propranolol is more than a cardiovascular tool: its non-selective β1 and β2 adrenergic blockade creates a valuable translational bridge across hemodynamics, neural-state regulation, emotional memory, and metabolism. This article outlines how researchers can convert that pharmacology into better-controlled experiments and clinically relevant hypotheses.

• KNUCKLES Controls Floral Meristem Termination

  2026-08-19

  This study identifies KNUCKLES as a transcriptional and chromatin-level coordinator of floral meristem termination in Arabidopsis. By repressing PIN1 and IPT7, KNUCKLES links auxin distribution and cytokinin activity with the established WUS–CLV3 stem-cell circuit, providing a mechanistic explanation for timely floral determinacy.

444 records 6/30 page Previous Next First page 上5页 678910 下5页 Last page